Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-005491
Filing Date
2024-07-17
Accepted
2024-07-17 16:23:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 12581
  Complete submission text file 0001950047-24-005491.txt   14117
Mailing Address C/O FLAGSHIP PIONEERING, INC. 55 CAMBRIDGE PARKWAY, SUITE 800E CAMBRIDGE MA 02142
Business Address
AFEYAN NOUBAR (Reporting) CIK: 0001222012 (see all company filings)

Type: 144

Mailing Address 325 BINNEY STREET CAMBRIDGE MA 02142
Business Address 325 BINNEY STREET CAMBRIDGE MA 02142 6177146500
Moderna, Inc. (Subject) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38753 | Film No.: 241122507
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)